Saturday, November 22, 2014

Comparison of the Efficacy of Rosuvastatin versus Atorvastatin in Preventing Contrast Induced Nephropathy in Patient with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention.

Rosuvastatin 10 mg and atorvastatin 20 mg given prior to angiography were found to be similarly effective in decreasing the risk of contrast induced nephropathy.  (PLoS One. 2014 Oct 30;9(10):e111124)
Read More